Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

225Ac

  • MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
    Open Access
    MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
    Julie Constanzo, Aliasghar Parach, Timothee David, Joshua Karam, Frank Bruchertseifer, Alfred Morgenstern, Marta Jarlier, Manuel Bardiès, Emmanuel Deshayes, Amelie Gudin-de-Vallerin, Florence Boissière-Michot, Evelyne Lopez-Crapez and Jean-Pierre Pouget
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 785-792; DOI: https://doi.org/10.2967/jnumed.124.268857
  • Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of <sup>225</sup>Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
    You have access
    Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
    Christian W. Wichmann, Katherine A. Morgan, Zhipeng Cao, Laura D. Osellame, Nancy Guo, Hui Gan, Edward Reilly, Ingrid J.G. Burvenich, Graeme J. O’Keefe, Paul S. Donnelly and Andrew M. Scott
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1456-1462; DOI: https://doi.org/10.2967/jnumed.123.266894
  • Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    You have access
    Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    Hendrik Rathke, Erik Winter, Frank Bruchertseifer, Manuel Röhrich, Frederik Lars Giesel, Uwe Haberkorn, Alfred Morgenstern and Clemens Kratochwil
    Journal of Nuclear Medicine July 1, 2024, 65 (7) 1057-1063; DOI: https://doi.org/10.2967/jnumed.123.267206
  • Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
    Open Access
    Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
    Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433
  • Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
    You have access
    Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
    Sebastian K. Chung, Daniela Burnes Vargas, Christopher S. Chandler, Sumudu Katugampola, Darren R. Veach, Michael R. McDevitt, Shin H. Seo, Brett A. Vaughn, Sara S. Rinne, Blesida Punzalan, Mitesh Patel, Hong Xu, Hong-Fen Guo, Pat B. Zanzonico, Sébastien Monette, Guangbin Yang, Ouathek Ouerfelli, Garrett M. Nash, Andrea Cercek, Edward K. Fung, Roger W. Howell, Steven M. Larson, Sarah M. Cheal and Nai-Kong V. Cheung
    Journal of Nuclear Medicine September 1, 2023, 64 (9) 1439-1445; DOI: https://doi.org/10.2967/jnumed.122.265095
  • Evaluation of <sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for <sup>225</sup>Ac α-Radiotherapeutics
    Open Access
    Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics
    Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin and Robert R. Flavell
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1076-1082; DOI: https://doi.org/10.2967/jnumed.122.265355
  • Signaling Network Response to α-Particle–Targeted Therapy with the <sup>225</sup>Ac-Labeled Minigastrin Analog <sup>225</sup>Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors
    Open Access
    Signaling Network Response to α-Particle–Targeted Therapy with the 225Ac-Labeled Minigastrin Analog 225Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors
    Yun Qin, Stefan Imobersteg, Stephan Frank, Alain Blanc, Tanja Chiorazzo, Philipp Berger, Roger Schibli, Martin P. Béhé and Michal Grzmil
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 873-879; DOI: https://doi.org/10.2967/jnumed.122.264597
  • Cure of Disseminated Human Lymphoma with [<sup>225</sup>Ac]Ac-Ofatumumab in a Preclinical Model
    Open Access
    Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
    Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek and Richard L. Wahl
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 924-931; DOI: https://doi.org/10.2967/jnumed.122.265167
  • You have access
    Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
    Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, Alfred Morgenstern, Matthias Eiber, Ken Herrmann and Kelsey L. Pomykala
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 685-692; DOI: https://doi.org/10.2967/jnumed.122.265353
  • Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered <strong>α</strong>-Particles May Realize the Promise for <sup>225</sup>Ac in Large, Solid Tumors
    You have access
    Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered α-Particles May Realize the Promise for 225Ac in Large, Solid Tumors
    Alaina Howe, Omkar Bhatavdekar, Dominick Salerno, Anders Josefsson, Jesus Pacheco-Torres, Zaver M. Bhujwalla, Kathleen L. Gabrielson, George Sgouros and Stavroula Sofou
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1223-1230; DOI: https://doi.org/10.2967/jnumed.121.262992

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire